By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellerant Therapeutics, Inc. 

1531 Industrial Road

San Carlos  California  94070  U.S.A.
Phone: 650-232-2122 Fax: 650-232-5495



Start Up

Company News
Cellerant Therapeutics, Inc. Presents Preclinical Data Showing Promise Of A Novel Differentiated Target On Leukemic Stem Cells 10/11/2016 10:53:39 AM
Cellerant Therapeutics, Inc. Awarded $1.5 Million SBIR Contract For Development Of Novel Antibody-Based Therapeutic Against IL1RAP 9/26/2016 10:57:45 AM
Cellerant Therapeutics, Inc. Appoints Rodney Young As Chief Financial Officer 6/16/2015 7:16:08 AM
Cellerant Therapeutics, Inc. Announces Dosing Of First Patient In Randomized Phase 2 Clinical Trial Of CLT-008 In Acute Myeloid Leukemia Patients 3/17/2015 7:24:54 AM
Cellerant Therapeutics, Inc. To Present Phase 1 Clinical Data On Evaluation Of CLT-008 In Patients With Acute Myeloid Leukemia At The 2014 American Society of Hematology Annual Meeting 12/8/2014 7:28:57 AM
Bay Area's Cellerant Therapeutics, Inc. Awarded $47.5 Million From The U.S. Government 9/11/2014 6:17:48 AM
Cellerant Therapeutics, Inc. Announces Timothy Fong As Vice President Of Cellular Technologies And Jagath Reddy Junutula As Vice President Of Antibody Discovery & Development 5/12/2014 7:17:29 AM
Cellerant Therapeutics, Inc. Awarded SBIR Contract Funding to Develop CLT-009 for Treatment of Thrombocytopenia 10/8/2012 9:52:09 AM
Cellerant Therapeutics, Inc. Awarded $36.4 Million Option Under Existing U.S. Government Contract to Support Development of CLT-008 for Treatment of Acute Radiation Syndrome 9/4/2012 10:02:48 AM
Cellerant Therapeutics, Inc. to Present at the International Society for Stem Cell Research 10th Annual Meeting in Japan 6/15/2012 10:23:37 AM